Trial no.:
|
PACTR201901699494129 |
Date of Approval:
|
25/01/2019 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effect of fluirbiprofen and lidocaine on sore throat due to the upper gastrointestinal system endoscopy |
Official scientific title |
Effect of fluirbiprofen and lidocaine on sore throat due to the upper gastrointestinal system endoscopy: Randomized controlled study |
Brief summary describing the background
and objectives of the trial
|
Upper Gastrointestinal System Local analgesic sprays (lidocaine 2%, 10%) are routinely used for sore throat due to endoscopy.
however, some patients experience sore throat during and after the procedure.
A fully active drug for the procedure has still not been found. In our study, we aimed to evaluate the efficacy of the nonsteroidal antiinflammatory flurbiprofen spray to prevent sore throat from upper gastrointestinal endoscopy. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Ear, Nose and Throat,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
05/12/2018 |
Actual trial start date |
|
Anticipated date of last follow up |
28/02/2019 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
150 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|